Skip to content
Open access

Possible sarcopenia defined by the 2025 Asian Working Group for sarcopenia consensus and functional impairment among adults aged 50–64 years: a longitudinal cohort study

Oct 2026 · The Journal of Nutrition, Health & Aging · Vol 30, pp. 101008 · 0 citations · 31 references
Medicine

TL;DR

AWGS 2025-defined possible sarcopenia and progression to possible sarcopenia were associated with ADL/IADL impairment in adults aged 50–64 years, supporting early screening and repeated monitoring in late midlife.

Abstract

Background The Asian Working Group for Sarcopenia (AWGS) 2025 consensus simplified possible sarcopenia assessment and extended it to adults aged 50–64 years, but its association with activities of daily living (ADL)/instrumental activities of daily living (IADL) impairment in this age group remains unclear. We therefore conducted cross-sectional and longitudinal analyses to address this gap. Methods Using China Health and Retirement Longitudinal Study data, we included 6,904 adults aged 50–64 years for cross-sectional analyses. After excluding participants with baseline impairment, 5,730 and 5,423 were followed through 2020 for incident ADL and IADL impairment, respectively. Transition analyses included 3,569 and 3,200 participants, respectively. Possible sarcopenia was defined as low handgrip strength according to the AWGS 2025 criterion. Multivariable logistic regression and discrete-time complementary log-log models were used. Results In cross-sectional analyses, possible sarcopenia was associated with higher odds of prevalent ADL (OR = 1.82, 95% CI = 1.53–2.17) and IADL (OR = 1.45, 95% CI = 1.23–1.71) impairment. Over up to 9 years, it was associated with increased hazards of incident ADL (HR = 1.42, 95% CI = 1.27–1.59) and IADL (HR = 1.36, 95% CI = 1.21–1.52) impairment. In transition analyses, progression to possible sarcopenia was associated with higher hazards of subsequent ADL (HR = 1.23, 95% CI = 1.01–1.49) and IADL (HR = 1.31, 95% CI = 1.07–1.61) impairment. Reversion to no possible sarcopenia was not significantly associated with ADL (HR = 0.84, 95% CI = 0.58–1.22) or IADL (HR = 0.77, 95% CI = 0.52–1.15) impairment. Conclusions AWGS 2025-defined possible sarcopenia and progression to possible sarcopenia were associated with ADL/IADL impairment in adults aged 50–64 years, supporting early screening and repeated monitoring in late midlife.

Read PDF

Similar papers

Open access 2026

[Sarcopenia, obesity, and limitations in daily activities in older adults from Elsi-Brazil: recommendations from the Sarcopenia Definition and Outcomes Consortium].

This study aimed to investigate the associations between isolated sarcopenia and its combination with general and abdominal obesity, stratified by sex, with limitations in basic (BADL) and instrumental (IADL) activities of daily living among Brazilian older adults. A cross-sectional study was conducted with 6,874 older...

Ana Lúcia Danielewicz, B. P. Freitas, Bruno de Souza Moreira et al. · 1 citation
Open access Oct 2026

RCII-frailty-sarcopenia burden and incident chronic lung disease: a prospective cohort study of Chinese middle-aged and older adults based on CHARLS

The remnant cholesterol inflammatory index (RCII) integrates remnant cholesterol with systemic inflammation. Whether RCII combined with frailty and sarcopenia is associated with subsequent reported chronic lung disease (CLD) remains unclear. We analysed a selected CHARLS cohort aged ≥45 years without repor...

Yan-Jun Lei, Si-Ye Zhang, Lu-Lu Zhang · 0 citations
Open access Oct 2026

Prevalence and factors associated with sarcopenia in individuals with stroke undergoing rehabilitation: A cross-sectional study

DXA-confirmed post-stroke sarcopenia affected approximately one in four individuals undergoing rehabilitation and was independently associated with lower BMI, poorer physical performance, and greater motor impairment.

F. S. Ida, Esther Joyce De Monte Castello E Silva, Gabriela De Souza Martins Brasil et al. · 0 citations
Open access Sep 2026

Multimorbidity and long-term condition burden as markers of incident sarcopenia risk: A prospective cohort study.

OBJECTIVE To examine sex-specific prospective associations of multimorbidity, cumulative long-term condition (LTC) burden, and individual LTCs with incident sarcopenia. METHODS This prospective cohort study included 47,417 UK Biobank participants without sarcopenia at baseline. Multimorbidity was defined as ≥2 LTCs,...

M. Guerrero-Wyss, S. Johnston, Carla M. Prado et al. · 0 citations
Open access Oct 2026

Prognostic validity of the Asian Working Group for Sarcopenia 2025 criteria in patients undergoing hemodialysis: A multicenter retrospective cohort study.

BACKGROUND Sarcopenia is highly prevalent among patients undergoing hemodialysis and predicts mortality. In November 2025, the Asian Working Group for Sarcopenia updated its diagnostic criteria (AWGS 2025), excluding physical performance; its prognostic significance remains unclear. Therefore, this study evaluated the...

Naoyuki Tsujimoto, R. Matsuzawa, M. Harada et al. · 0 citations
Open access Sep 2026

Handgrip strength asymmetry and cardiometabolic multimorbidity in Chinese middle-aged and older adults: a longitudinal cohort study.

BACKGROUND Handgrip strength asymmetry has been associated with adverse health outcomes, but its longitudinal association with incident cardiometabolic multimorbidity (CMM) remains unclear. We examined this association and conducted exploratory analyses across sleep duration and restless-sleep frequency categories. M...

Yu Huang, Lei Huang, Yan-Wen Gao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.